Last reviewed · How we verify

NCT04115046

The EUS ShearWave Elastography Liver Fibrosis Study

Completed Last updated 9 September 2021
What this trial tests

trial testing ShearWave Elastography (SWE) in Endoscopic Ultrasound (EUS) in Liver Fibroses in 52 participants. Completed in 17 May 2021.

Timeline
14 July 2020
Primary endpoint
26 April 2021
17 May 2021

Quick facts

Lead sponsorOlympus Corporation of the Americas
StatusCompleted
Study typeOBSERVATIONAL
Enrollment52
Start date14 July 2020
Primary completion26 April 2021
Estimated completion17 May 2021
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Olympus Corporation of the Americas

Who can join

Adults 18 to 100, any sex, with Liver Fibroses. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study objective is to demonstrate the clinical performance of ShearWave Elastography (SWE) in Endoscopic Ultrasound (EUS) when compared to FibroScan for evaluation of liver fibrosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The Role of Endoscopic Ultrasound in Assessing Portal Hypertension: A State-of-the-Art Literature Review and Evolving Perspectives.
    Termite F, Borrelli de Andreis F, Liguori A, Gasbarrini A, et al · · 2025 · cited 1× · PMID 39601324 · DOI 10.1111/liv.16176

Verify or expand the search:

Other recruiting trials for Liver Fibroses

Currently open trials in the same condition.

Other Olympus Corporation of the Americas trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04115046.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing